Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: U.S. Census; Chart: Andrew Witherspoon

Roughly 40% of Americans have postponed getting medical care due to the coronavirus outbreak. That number has stayed around 40% in all 12 weeks of the Census Bureau's Household Pulse Survey.

Why it matters: Hospitals and doctors started rescheduling surgeries and other appointments as early as mid-May, and many patient volumes are mostly back to pre-pandemic numbers. But this data suggests there is still a major backlog of Americans who need care — a phenomenon that existed well before the pandemic.

Go deeper

White House urges Iowa to tighten restrictions as COVID-19 surges

Reynolds meets with Trump in May. Photo: Saul Loeb/AFP via Getty Images

Iowa is experiencing an "unyielding COVID spread," illustrated by swelling hospital admissions and ICU data, according to a Nov. 8 White House Coronavirus Task Force report obtained by the local ABC News affiliate.

Driving the news: Iowa Gov. Kim Reynolds, who has repeatedly said that strict rules were unnecessary and ineffective, on Tuesday issued limits on large gatherings and implemented a partial mask mandate for social settings and some businesses.

Fauci: Working with Trump administration has "been very stressful"

Anthony Fauci. Photo: GRAEME JENNINGS/POOL/AFP via Getty Images

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a Wednesday interview that working alongside the Trump administration to combat the coronavirus in the U.S. has been "very stressful."

Why it matters: Although Fauci, who considers himself apolitical, is among the most trusted voices in the country on the coronavirus, he has faced attacks from Trump loyalists and the president himself, who recently called him a "disaster."

Nov 11, 2020 - Health

EU purchases 200 million doses of Pfizer's COVID-19 vaccine

Illustration: Sarah Grillo/Axios

The European Union struck a deal with Pfizer and BioNTech to buy at least 200 million doses of their coronavirus vaccine in the largest initial order to date, the companies announced Wednesday.

Driving the news: Pharmaceutical giant Pfizer announced Monday that its coronavirus vaccine trial was effective in preventing COVID-19 infections in 90% of previously uninfected people and did not produce any serious safety concerns.